Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Notice: Multiple Additions to the Prescription Drug List (PDL) Date: January 24, 2022 Our file number: 22-100898-943 The purpose of this Notice of Amendment is to notify about the additions of Anifrolumab, Avalglucosidase alfa, Dostarlimab, Fostemsavir, Palovarotene and…
Guidance Document: Regulatory Requirements for Drug Identification Numbers (DINs) - Summary Download the PDF format (700 KB, 31 pages) Organization: Health Canada Date published: 2025-02-18 Drug Product Database Guide to Reporting Drug Shortages and Discontinuations Guidance…
Summary of findings and advice: Scientific Advisory Committee on Health Products for Women (SAC-HPW) October 27th, 2021 virtual meeting via Zoom Context The mandate of the Scientific Advisory Committee on Health Products for Women (SAC-HPW) is to provide Health Canada with…
Drug shortages in Canada: Regulations and guidance Overview Information for consumers Information for industry Regulations and guidance Information for health care providers Multi-stakeholder steering committee On this page About the regulatory provisions for drug shortages…
Research Ethics Board attestation This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below. (PDF Version - 198 KB) (Microsoft Word version - 115…
Qualified investigator undertaking This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below. (Microsoft Word version - 117 KB) ( PDF version -…
Notice of Amendment: Tramadol removed from the Prescription Drug List (PDL) March 31, 2022 Our file number: 22-103686-802 The purpose of this Notice of Amendment is to notify that Health Canada has removed tramadol from the Prescription Drug List (PDL) and added it to Schedule I…
Qualifying notice for Bavencio Biologics and Genetic Therapies Directorate 100 Eglantine Driveway Address Locator #0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e196892 Control #: 208742 Document #: 1309699 [employee name removed] [employee title removed] EMD Serono, A Division of…
Switching a medicinal ingredient from prescription to non-prescription status guidance document: Closed consultation Current status: Closed This consultation ran from April 21, 2022 to June 20, 2022. Health Canada has updated the current guidance document for companies who wish…
Notice – Interim implementation of electronic labelling for human prescription drugs April 22, 2022 Our file number: 21-120620 – 181 Consultation on the draft guidance " Electronic media in prescription drug labelling " was open between March 12, 2021 and May 7, 2021. Based on…
Early release: coverage and features are still expanding.
